A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02279823 |
Recruitment Status :
Completed
First Posted : October 31, 2014
Last Update Posted : March 13, 2017
|
Sponsor:
Intrepid Therapeutics, Inc.
Information provided by (Responsible Party):
Intrepid Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | December 2015 |
Actual Study Completion Date : | May 2016 |
Certification/Extension First Submitted : | March 9, 2017 |